• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过靶向质谱法对正常和高脂血症小鼠的血浆载脂蛋白组进行分析。

Profiling the Plasma Apolipoproteome of Normo- and Hyperlipidemic Mice by Targeted Mass Spectrometry.

机构信息

Unit of Cardiovascular and Renal Research, Department of Molecular Medicine, University of Southern Denmark, 5000 Odense C, Denmark.

Department of Clinical Biochemistry, Odense University Hospital, 5000 Odense C, Denmark.

出版信息

J Proteome Res. 2023 May 5;22(5):1385-1393. doi: 10.1021/acs.jproteome.2c00189. Epub 2022 Jun 14.

DOI:10.1021/acs.jproteome.2c00189
PMID:35700353
Abstract

Atherosclerotic cardiovascular disease is the leading cause of death worldwide. For decades, mouse modeling of atherosclerosis has been the mainstay for preclinical testing of genetic and pharmacological intervention. Mouse models of atherosclerosis depend on supraphysiological levels of circulating cholesterol carried in lipoprotein particles. Lipoprotein particles vary in atherogenicity, and it is critical to monitor lipoprotein levels during preclinical interventions in mice. Unfortunately, the small plasma volumes typically harvested during preclinical experiments limit analyses to measuring total cholesterol and triglyceride levels. Here we developed a high-throughput, low-cost targeted multiple reaction monitoring (MRM) stable isotope dilution (SID) mass spectrometry assay for simultaneous relative quantification of nine apolipoproteins using a few microliters of mouse plasma. We applied the MRM assay to investigate the plasma apolipoproteome of two atherosclerosis models: the widely used ApoE knockout model and the emerging recombinant adeno-associated virus-mediated hepatic Pcsk9 overexpression model. By applying the assay on size-exclusion chromatography-separated plasma pools, we provide in-depth characterization of apolipoprotein distribution across lipoprotein species in these models, and finally, we use the assay to quantify apolipoprotein deposition in mouse atherosclerotic plaques. Taken together, we report development and application of an MRM assay that can be adopted by fellow researchers to monitor the mouse plasma apolipoproteome during preclinical investigations.

摘要

动脉粥样硬化性心血管疾病是全球范围内的主要死亡原因。几十年来,动脉粥样硬化的小鼠模型一直是遗传和药物干预的临床前测试的主要方法。动脉粥样硬化的小鼠模型依赖于脂蛋白颗粒中载脂蛋白颗粒的超生理水平循环胆固醇。脂蛋白颗粒的致动脉粥样硬化性不同,在小鼠的临床前干预期间监测脂蛋白水平至关重要。不幸的是,临床前实验中通常采集的小血浆量限制了分析只能测量总胆固醇和甘油三酯水平。在这里,我们开发了一种高通量、低成本的靶向多重反应监测(MRM)稳定同位素稀释(SID)质谱测定法,使用几微升小鼠血浆即可同时相对定量 9 种载脂蛋白。我们应用 MRM 测定法研究了两种动脉粥样硬化模型的血浆载脂蛋白组:广泛使用的 ApoE 敲除模型和新兴的重组腺相关病毒介导的肝 Pcsk9 过表达模型。通过应用该测定法对尺寸排阻色谱分离的血浆池进行分析,我们深入描述了这些模型中载脂蛋白在脂蛋白种类中的分布情况,最后,我们使用该测定法定量了小鼠动脉粥样硬化斑块中的载脂蛋白沉积。总之,我们报告了一种 MRM 测定法的开发和应用,该测定法可以被同行研究人员采用,以在临床前研究中监测小鼠血浆载脂蛋白组。

相似文献

1
Profiling the Plasma Apolipoproteome of Normo- and Hyperlipidemic Mice by Targeted Mass Spectrometry.通过靶向质谱法对正常和高脂血症小鼠的血浆载脂蛋白组进行分析。
J Proteome Res. 2023 May 5;22(5):1385-1393. doi: 10.1021/acs.jproteome.2c00189. Epub 2022 Jun 14.
2
Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.通过单腺相关病毒介导的突变型人前蛋白转化酶枯草溶菌素9基因转移诱导持续性高胆固醇血症
Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):50-9. doi: 10.1161/ATVBAHA.114.303617. Epub 2014 Oct 23.
3
PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE.在缺乏载脂蛋白E的情况下,前蛋白转化酶枯草溶菌素9(PCSK9)抑制作用无法改变肝脏低密度脂蛋白受体、循环胆固醇及动脉粥样硬化情况。
J Lipid Res. 2014 Nov;55(11):2370-9. doi: 10.1194/jlr.M053207. Epub 2014 Sep 25.
4
Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.人类前蛋白转化酶枯草溶菌素9通过载脂蛋白E和低密度脂蛋白受体介导的机制促进肝脏脂肪生成和动脉粥样硬化发展。
Cardiovasc Res. 2016 May 15;110(2):268-78. doi: 10.1093/cvr/cvw053. Epub 2016 Mar 15.
5
Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.瑞舒伐他汀独立于降低血浆胆固醇水平减少载脂蛋白 E/清道夫受体 B1 双重基因敲除小鼠主动脉窦和冠状动脉粥样硬化
Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):26-39. doi: 10.1161/ATVBAHA.117.305140. Epub 2017 Nov 21.
6
Hypoxia inducible factor 1α inhibitor PX-478 reduces atherosclerosis in mice.缺氧诱导因子 1α 抑制剂 PX-478 可减少小鼠动脉粥样硬化。
Atherosclerosis. 2022 Mar;344:20-30. doi: 10.1016/j.atherosclerosis.2022.01.002. Epub 2022 Jan 21.
7
Mouse models of atherosclerosis in translational research.动脉粥样硬化的小鼠模型在转化研究中的应用。
Trends Pharmacol Sci. 2022 Nov;43(11):920-939. doi: 10.1016/j.tips.2022.06.009. Epub 2022 Jul 25.
8
A novel mouse model of diabetes, atherosclerosis and fatty liver disease using an AAV8-PCSK9-D377Y injection and dietary manipulation in db/db mice.一种新型糖尿病、动脉粥样硬化和脂肪肝疾病的小鼠模型,通过 AAV8-PCSK9-D377Y 注射和 db/db 小鼠的饮食干预来建立。
Biochem Biophys Res Commun. 2022 Sep 24;622:163-169. doi: 10.1016/j.bbrc.2022.07.031. Epub 2022 Jul 15.
9
Ablation of Plasma Prekallikrein Decreases Low-Density Lipoprotein Cholesterol by Stabilizing Low-Density Lipoprotein Receptor and Protects Against Atherosclerosis.血浆激肽释放酶原的消融通过稳定低密度脂蛋白受体降低低密度脂蛋白胆固醇并预防动脉粥样硬化。
Circulation. 2022 Mar;145(9):675-687. doi: 10.1161/CIRCULATIONAHA.121.056491. Epub 2022 Feb 22.
10
Efficacy of Shoushen granule on adenosine triphosphate binding cassette transporter A1, proprotein convertase subtilisin/kexin type 9 and toll-like receptor 4/nuclear factor kappa-B signaling pathway in ApoE-knockout mice.寿身颗粒对载脂蛋白 E 基因敲除小鼠三磷酸腺苷结合盒转运体 A1、蛋白水解酶枯草杆菌蛋白酶/κexin 型 9 和 Toll 样受体 4/核因子 kappa-B 信号通路的影响。
J Tradit Chin Med. 2019 Aug;39(4):524-534.

引用本文的文献

1
The cardio-metabolic protein profile is associated with development of type 2 diabetes at long term follow-up after gestational diabetes mellitus: Results from the OGFUS study.在妊娠期糖尿病后的长期随访中,心脏代谢蛋白谱与2型糖尿病的发生相关:OGFUS研究结果
Diabetes Obes Metab. 2025 Mar;27(3):1456-1465. doi: 10.1111/dom.16148. Epub 2025 Jan 2.